個性化治療方案聯(lián)合中醫(yī)治療干預對高血壓患者免疫功能及血壓的影響
[Abstract]:Objective: to explore the effect of individualized therapy combined with acupuncture and moxibustion combined with salvia miltiorrhiza intravenous drip on immune function and blood pressure in patients with hypertension. Methods: a total of 570 patients in the Department of Cardiology from January 1, 2013 to December 31, 2014 were selected and divided into observation group and control group according to the minimum imbalance index method. Patients in the observation group and control group were treated with individualized treatment combined with acupuncture and moxibustion of traditional Chinese medicine combined with intravenous infusion of salvia miltiorrhiza injection, while the patients in the control group received only 5% glucose intravenously. The changes of T cell subsets, immunoglobulin, CIC,CRP,PIP and blood pressure were compared between the two groups. Results: the difference of CD3,CD4,CD8,CD_4~ / CD_8~ between the observation group and the control group was statistically significant (t = 2.62 鹵2.07 ~ 2.61 ~ 2.21) P = 0.01 ~ 0.04 ~ 0.01 ~ 0.03). There was no significant difference in IgM between the observation group and the control group after treatment (t = 1.83), but there was a significant difference between the observation group and the control group after the treatment of total IgG,IgA, Ig (t = 2.71 鹵2.65, P 0.05). There was no difference in systolic blood pressure, diastolic blood pressure and blood pressure control rate between experimental group and control group before treatment (P0.05). After treatment, systolic blood pressure and diastolic blood pressure in experimental group were lower than those in control group (P0.05), and blood pressure control rate in experimental group was higher than that in control group (P0.05). Conclusion: the individualized therapy combined with acupuncture and moxibustion combined with salvia miltiorrhiza intravenous drip can further improve the humoral and cellular immune function of the patients and improve the blood pressure control rate of the patients.
【作者單位】: 棗礦集團中心醫(yī)院心內(nèi)科;棗礦集團甘霖礦醫(yī)院;
【基金】:青島市中醫(yī)科研計劃項目(2014-zyz002)
【分類號】:R544.1
【相似文獻】
相關(guān)期刊論文 前10條
1 邢莉,陳建東;赴美移民人群高血壓相關(guān)因素的探討[J];中國國境衛(wèi)生檢疫雜志;2004年04期
2 蔡淑蘭;陳長香;王建輝;王尚書;;高血壓患者血壓水平對記憶功能的影響[J];中國老年學雜志;2012年11期
3 李坤;陳大方;石紅梅;周曉云;;某城區(qū)2012年高血壓患者知識及行為的現(xiàn)況調(diào)查[J];慢性病學雜志;2013年04期
4 劉力生;;影響高血壓的因素[J];心血管病防治知識;2005年06期
5 余學清,王文健;腎實質(zhì)性高血壓的診斷與治療進展[J];醫(yī)師進修雜志;2001年08期
6 王振果,顧凱,李德錄,李新建,韓阿琴;上海社區(qū)高血壓分級管理模式初探[J];中國慢性病預防與控制;2001年04期
7 高桂琴,黃明煒,李敬會;高血壓患者降壓治療繼發(fā)性失敗原因初探[J];臨床薈萃;2002年04期
8 劉潤梅;腎實質(zhì)性高血壓[J];人民軍醫(yī);2003年02期
9 鄺明子,黃虔,曾廣民,李光召,林小茂;藥費對高血壓堅持治療率的影響[J];心臟雜志;2004年04期
10 談乃良,張才方;農(nóng)村社區(qū)高血壓分級管理現(xiàn)狀分析[J];上海預防醫(yī)學雜志;2004年12期
相關(guān)會議論文 前10條
1 何重榮;;高血壓與睡眠[A];加入WTO和中國科技與可持續(xù)發(fā)展——挑戰(zhàn)與機遇、責任和對策(下冊)[C];2002年
2 劉建一;;血壓分級的修訂對高血壓治療的意義[A];中華醫(yī)學會第十五次全國心血管病學大會論文匯編[C];2013年
3 何展明;;白云區(qū)683例居民高血壓及其相關(guān)因素調(diào)查[A];2011廣東省預防醫(yī)學會學術(shù)年會資料匯編[C];2011年
4 徐偉;朱瑜;沈樂賢;吳益生;李新建;;閘北區(qū)社區(qū)高血壓分級管理效果評價[A];上海市預防醫(yī)學會第二屆學術(shù)年會論文匯編[C];2006年
5 徐海娜;張建豐;;長慶社區(qū)中青年高血壓患者風險因素調(diào)查[A];2012年浙江省全科醫(yī)學學術(shù)年會論文匯編[C];2012年
6 孫緒峰;;提高服藥依從性規(guī)范管理高血壓患者模式探索[A];中國心臟大會(CHC)2011暨北京國際心血管病論壇論文集[C];2011年
7 董國萍;;紹興市靈芝鎮(zhèn)高血壓社區(qū)綜合干預的效果評價[A];浙江省第二十屆基層衛(wèi)生改革與發(fā)展學術(shù)會議大會論文集[C];2012年
8 云美玲;;海南黎族高血壓合并動脈硬化患者血管緊張素轉(zhuǎn)換酶基因多態(tài)性與頸動脈粥樣硬化的相關(guān)性[A];第十三次全國心血管病學術(shù)會議論文集[C];2011年
9 王振W,
本文編號:2291888
本文鏈接:http://sikaile.net/yixuelunwen/xxg/2291888.html